The incidence ratio of high-grade adverse events to all-grade adverse events revealed thrombocytopenia, neutropenia, anaemia, ALT increase, and AST increase tend to be severe (a higher probability to be high grade when these adverse events occurred). The gene discussed is GPT; the disease is neutropenia.